These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10577983)

  • 21. [Recommendations of the Deutschen Gesellschaft für Rheumatologie on therapy of rheumatoid arthritis with the interleukin-1-receptor-antagonist Akakinra (KINERET)].
    Manger B;
    Z Rheumatol; 2002 Dec; 61(6):698-700. PubMed ID: 12491134
    [No Abstract]   [Full Text] [Related]  

  • 22. Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases.
    Hallegua DS; Weisman MH
    Ann Rheum Dis; 2002 Nov; 61(11):960-7. PubMed ID: 12379516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis.
    Furst DE
    Clin Ther; 2004 Dec; 26(12):1960-75. PubMed ID: 15823761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concomitant medication use in a large, international, multicenter, placebo controlled trial of anakinra, a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis.
    Tesser J; Fleischmann R; Dore R; Bennett R; Solinger A; Joh T; Modafferi D; Schechtman J;
    J Rheumatol; 2004 Apr; 31(4):649-54. PubMed ID: 15088288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis.
    Schiff MH
    Ann Rheum Dis; 2000 Nov; 59 Suppl 1(Suppl 1):i103-8. PubMed ID: 11053099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores.
    Jiang Y; Genant HK; Watt I; Cobby M; Bresnihan B; Aitchison R; McCabe D
    Arthritis Rheum; 2000 May; 43(5):1001-9. PubMed ID: 10817552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.
    Cohen SB; Moreland LW; Cush JJ; Greenwald MW; Block S; Shergy WJ; Hanrahan PS; Kraishi MM; Patel A; Sun G; Bear MB;
    Ann Rheum Dis; 2004 Sep; 63(9):1062-8. PubMed ID: 15082469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of interleukin-1 blockade on fatigue in rheumatoid arthritis--a pilot study.
    Omdal R; Gunnarsson R
    Rheumatol Int; 2005 Aug; 25(6):481-4. PubMed ID: 15071755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kineret. Easing the pain of rheumatoid arthritis.
    Nursing; 2002 Apr; 32(4):26. PubMed ID: 11969009
    [No Abstract]   [Full Text] [Related]  

  • 30. [New drugs and treatment strategies for rheumatoid arthritis].
    Fantini F
    Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using anakinra for adult rheumatoid arthritis.
    Kastanek L
    Nurse Pract; 2002 Apr; 27(4):62-5. PubMed ID: 11984420
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of chronic polyarthritis with a human recombinant interleukin 1 receptor antagonist].
    Rau R; Sander O; Musikic P
    Z Rheumatol; 1998 Oct; 57(5):312-9. PubMed ID: 9864837
    [No Abstract]   [Full Text] [Related]  

  • 33. Anakinra for arthritis.
    Pestell K
    Trends Pharmacol Sci; 2001 Aug; 22(8):401. PubMed ID: 11478998
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapeutic use of "biologics" in inflammatory joint and spinal diseases].
    Seitz M
    Ther Umsch; 2002 Oct; 59(10):535-43. PubMed ID: 12428439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anakinra (Kineret) for rheumatoid arthritis.
    Med Lett Drugs Ther; 2002 Feb; 44(1124):18-9. PubMed ID: 11856953
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis.
    Cohen SB
    Rheum Dis Clin North Am; 2004 May; 30(2):365-80, vii. PubMed ID: 15172046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anakinra as a new therapeutic option in rheumatoid arthritis: clinical results and perspectives.
    Bresnihan B
    Clin Exp Rheumatol; 2002; 20(5 Suppl 27):S32-4. PubMed ID: 14989427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beneficial response to interleukin 1 receptor antagonist in traps.
    Simon A; Bodar EJ; van der Hilst JC; van der Meer JW; Fiselier TJ; Cuppen MP; Drenth JP
    Am J Med; 2004 Aug; 117(3):208-10. PubMed ID: 15300976
    [No Abstract]   [Full Text] [Related]  

  • 39. Addressing the safety of anakinra in patients with rheumatoid arthritis.
    Fleischmann RM
    Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii29-35. PubMed ID: 12817093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel therapies for treatment of rheumatoid arthritis.
    Piascik P
    J Am Pharm Assoc (Wash); 1997; NS37(1):14-6. PubMed ID: 9040165
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.